PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Pinunta Nittayacharn

Department of Radiology, Case Western Reserve University, Cleveland, OH, United States.

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 11, 2026 · JOURNAL ARTICLE

Preclinical evaluation of PSMA-targeted ultrasound contrast agents in an orthotopic model of prostate cancer in rabbits.

Bioactive Materials

First-in-vivo preclinical study of a novel PSMA-targeted nanobubble contrast agent in an orthotopic rabbit model, demonstrating proof-of-concept with exploratory endpoints constrained by small cohort size and non-specific histologic validation.

PreliminarySidhartha Tavri Pinunta Nittayacharn Eric C Abenojar

Reported

Peak intensity ratio (tumor core,…1.60-fold

Peak intensity ratio (tumor rim,…1.50-fold

Mean transit time ratio (PSMA-NB…4.20 to 5.40-fold

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support